What is PTC Therapeutics's total revenue?

PTC Therapeutics (PTCT) reported total revenue of $272.55M in Q1 2026.

How has PTC Therapeutics's total revenue changed year-over-year?

PTC Therapeutics's total revenue decreased by 76.8% year-over-year, from $1.18B to $272.55M.

What is the long-term trend for PTC Therapeutics's total revenue?

Over 4 years (2021 to 2025), PTC Therapeutics's total revenue has grown at a 33.9% compound annual growth rate (CAGR), from $538.59M to $1.73B.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

PTC Therapeutics PTCT Total Revenue

Total Revenue at other companies

BioMarin PharmaceuticalsBMRN

$766.21M+2.8%

BridgeBio PharmaBBIO

$194.52M+66.8%

Arrowhead ResearchARWR

$73.74M-86.4%

United TherapeuticsUTHR

$781.5M-1.6%

BiogenBIIB

$2.48B+1.9%

ALN

Alnylam PharmaceuticalsALNY

——

Segments

By product

See full

Translarna1$235.3M—

Sephience$124.55M—

Translarna$58.98M—

Emflaza$21.48M—

Other Products$10.97M—

Upstaza And Kebilidi$9.59M—

By geography

See full

US$63.77M—

RU$21.49M—

BR$14.65M—

By segment

See full

Life Science$272.55M-76.8%

Other financials

Income statement

See full

Operating income$45.0M-95.4%

Net income-$2.8M-100%

EPS (diluted)-$0.03-100%

Balance sheet

See full

Cash & equivalents$834.0M-43.7%

Total debt$395.1M+0.1%

Total equity-$180.5M+2.9%

Total assets$2.9B+8.0%

Cash flow

See full

Operating cash flow-$59.0M-107%

CapEx$1.2M-30.6%

Free cash flow-$60.2M-107%

Valuation

See full

Market cap$6.55B+40.3%

Enterprise value$6.11B+77.3%

P/E8×—

P/S7.9×+5.3×

Profitability

See full

Gross margin96%—

Operating margin1.6%-38.7pp

Net margin42.3%+27.4pp

FCF margin39.1%+32.8pp

Returns & leverage

See full

Return on equity-216.7%—

Debt / equity372.3×—

Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PTC Therapeutics's total revenue?: PTC Therapeutics (PTCT) reported total revenue of $272.55M in Q1 2026.
How has PTC Therapeutics's total revenue changed year-over-year?: PTC Therapeutics's total revenue decreased by 76.8% year-over-year, from $1.18B to $272.55M.
What is the long-term trend for PTC Therapeutics's total revenue?: Over 4 years (2021 to 2025), PTC Therapeutics's total revenue has grown at a 33.9% compound annual growth rate (CAGR), from $538.59M to $1.73B.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.